Home Newsletters Hematopoiesis News Lipase-Triggered Drug Release from BCL2 Inhibitor ABT-199-Loaded Nanoparticles to Elevate Anti-leukemic Activity...

Lipase-Triggered Drug Release from BCL2 Inhibitor ABT-199-Loaded Nanoparticles to Elevate Anti-leukemic Activity through Enhanced Drug Targeting on the Mitochondrial Membrane

By
Justin.choi
-
0
Researchers compared the anti-leukemic ability of pure ABT-199 and PEG-ABT-199 in vitro and in vivo.
[Acta Biomaterialia]

Sorry, but the selected Zotpress account can't be found.

AbstractGraphical Abstract

RELATED ARTICLES

Exit mobile version